Be a part of 3^rd International Conference on ENT

Session 1: Otorhinolaryngology
Otorhinolaryngology or ENT (ear, nose, and throat) diseases is a medical field specializing in the diagnosis and treatment of patients with symptoms, diseases, or injuries in the ears, nose, paranasal sinuses, mouth, pharynx, larynx, or neck. Current research in Otorhinolaryngology is focused to improve treatments and outcomes for people with conditions of the ear, nose, throat, head, and neck.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums 
Session 2: Obstructive Sleep Apnea and Snoring (OSA)
Common sleep disorders like insomnia, restless legs syndrome, narcolepsy, and sleep apnea can affect every aspect of your life including your safety, relationships, school, work performance, thinking, mental health, weight, and the development of diabetes and heart disease. Not getting enough quality sleep can hurt your quality of life. This session deals with types of sleep disorders, causes and symptoms of sleep disorders, Diagnosis and Tests, Management and Treatment, Prevention, and Prognosis.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 3: Pediatric Otorhinolaryngology
Pediatric Otolaryngology deals with the illnesses of Ear, Nose, and Throat in children. Some children with ENT diseases need special care because of complicating medical conditions, such as asthma, heart disease, or developmental disorders. Hence pediatric otolaryngology can be considered a subspecialty of otolaryngology.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 4: Otology and Neurotology
Otology is a subspecialty of otolaryngology that focuses on the diseases of the ear and its connecting structures. Neurotology or neuro-otology is a branch of clinical medicine that studies and treats neurological disorders of the ear, and is closely related to otology, and also draws on the fields of neurology and neurosurgery. This session is designed in order to discuss the latest technology and techniques, including microsurgery, reconstructive surgery, and implantable hearing devices.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 5: Rhinoplasty and Nasal Reconstruction
Rhinoplasty & Nasal Reconstruction is a subspecialty of Otorhinolaryngology that manages nasal and sinus problems such as allergies, nasal obstruction, and sinusitis. The treatments in the department of Rhinology are tumors of the sinuses or anterior skull base, nasal polyps, rhinoplasty, and septoplasty. This session offers to gain knowledge in the development of surgical devices and procedures to treat nose and sinus problems.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 6: Thyroid Cancer and Parathyroid Disease
Thyroid Cancer/Parathyroid Disease is one of the areas that otolaryngology treats. This session is to discuss the diagnosis and treatment for Thyroid nodules, Hyperthyroidism, Hypothyroidism, Hypoparathyroidism, Hyperparathyroidism
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 7: Laryngology
Laryngology is a subspecialty of ENT (Otolaryngology) that deals with problems and injuries of the larynx, often called the voice box. This session deals with the latest advancements, diagnostic approaches, factors causing larynx disorders, and therapeutical approaches in the treatment of larynx disorders.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 8: Anesthesia in ENT Surgery
The preoperative and postoperative complications in the surgeries of ear, nose, throat, head, and neck can be managed by anesthesia and pain relievers. Anesthetic management in ENT procedures, including adenotonsillectomy, oesophagoscopy, and middle ear surgery will be discussed along with their complications and preoperative aspects to be considered.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 9: Head and Neck Surgery
Head and Neck Surgery is a dynamic new approach that allows surgeons to remove cancers of the head and neck with the use of specialized endoscopes and cameras without external incisions and usually with little or no change in speech, appearance, and swallowing function. The goals of head and neck surgery are to develop innovative therapies, and translational research, and to minimize the risks and recovery time.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 10: Facial and Plastic Surgery
Facial plastic surgery is a broad field of otolaryngology surgery that involves reconstructive and cosmetic techniques in addition to the use of biomaterials, lasers, and other adjunct materials to improve outcomes. The scope of facial plastic surgery includes rhinoplasty, browlifts, blepharoplasty, facelifts, microvascular reconstruction of the head and neck, craniomaxillofacial trauma reconstruction, and correction of defects in the face after skin cancer resection.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums
Session 11: Speech Pathology and Therapy
Speech-language pathologists evaluate and treat people with communication disorders. The Department of Speech Pathology deals with the identification, measurement, and study of hearing and hearing impairments and with the treatment of persons with hearing disorders, diagnosis & treatment of individuals with speech, language, voice, literacy, and fluency disorders.
ENT Conferences | ENT Meetings | ENT Summits | ENT Events | ENT Workshops | ENT Symposiums

With the increase in the predominance of ear, nose, and throat disorders in geriatric people, the demand for ENT devices is expected to drive the ENT devices industry rapidly over the upcoming years. Expanding heights of healthcare awareness among patients and healthcare professionals are expected to increase the growth of the market over the forecast period. The presence of sophisticated healthcare infrastructure in the communities, and favorable government initiatives led to progress and demand for ENT devices across underdeveloped countries owed to the extensive research and development targeted at developing technologically advanced products.
Importance and scope:
ENT is the branch of medicine that deals with the diagnosis, treatment, and other complications related to ears, nose, and throat, as well as the head and neck, mouth, sinuses, and larynx. The increasing use of some of the electric systems is partially caused by the growing attractiveness of access control systems which take less time for diagnosis, and treatment, and fewer damages through the time of surgery with minute pain. Increasing age leads to growth risk for ENT disorders. This results in the use of advanced laser and radiofrequency technology through surgical and diagnostic procedures and is predictable to drive ENT devices market size rapidly in coming forecast periods.
Target Audience:
• Drug Manufacturing Companies
• Otorhinolaryngology Societies
• Young Researchers
• Students & Delegates
• Entrepreneurs
• Research Scholars
• Service Professionals
• Scientists
The ENT devices market consists of sales of ENT devices and related services by entities (organizations, sole traders, and partnerships) that produce ENT devices used in the diagnosis and treatment of ear, nose, and throat diseases. This market is segmented into hearing aid devices and equipment; hearing diagnostic devices and equipment; ENT surgical devices and equipment; hearing implants; voice prosthesis devices and equipment; nasal splints. The global ENT devices market is expected to grow from $12.49 billion in 2020 to $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 15.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The ENT devices market is expected to reach $18.24 billion in 2025 at a CAGR of 6%.
North America was the largest region in the global ENT devices market, accounting for 33% of the market in 2020. Asia Pacific was the second largest region, accounting for 31% of the global ENT devices market. Africa was the smallest region in the global ENT devices market. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2018, the Indian government launched a new national health protection program that provided health coverage of up to Rs. 5 lakh ($7,100) per family for secondary and tertiary care hospitalization. The healthcare services market in the UK increased from $289 billion in 2016 to $300.8 billion in 2019. Favorable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for ENT devices during this period.
Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise up to 3.5% by 2023. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus Ostia and use the body’s natural mucosal fluids to expand the device.
The major players covered in the global ENT devices market are Sonova Holdings AG, William Demant Holdings A/S, Medtronic plc, KARL STORZ GmbH & Co, and Stryker Corporation.
The countries covered in the global ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam. The regions covered in the global ENT devices market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The global ENT devices market is segmented
• By Type: Hearing Aid Devices and Equipment, Hearing Diagnostic Devices and Equipment, ENT Surgical Devices and Equipment, Hearing Implants, Voice Prosthesis Devices, and Equipment, Nasal Splints
• By End User: Hospitals and Clinics, Diagnostic Laboratories, Others
• By Type of Expenditure: Public, Private
• By Product: Instruments/Equipment, Disposables
Why attend?
ENT 2023 is an international platform for presenting research about diagnosis, prevention, and management and exchanging ideas about it and thus, contributes to the dissemination of knowledge in Otorhinolaryngology for the benefit of both academia and business. The organizing committee of this ENT Conference is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations, and various programs for participants from all over the world. We invite you to join us at the ENT 2023, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the ENT 2023 and Organizing Committee look forward to meeting you in Paris, France.

The 3^rd International Conference on ENT helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts, or newsletters, provide clients with the very best customized marketing opportunities in science and medicine. We are one of the renowned event-organizing platforms with the most eminent speakers and business audiences from all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company. If you are looking for global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have an engaged audience of students, research scholars, scientists, doctors, professors, pharmacists, and professionals from companies across the domains. We maintain high quality and ethical standards in the publication industry, which make us unique and better than the rest. Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals, or relevant equipment or services, here is the opportunity to advertise on the website that can connect you to leading experts and science specialists worldwide. Meetings International is a global leader in producing high-quality conferences, meetings, workshops, and symposia in all major fields of science, technology, and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations, and high-level individuals, dedicated to hosting world-class conferences and events. Meetings International supports broad-scope research and peer review by a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry. Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, and instruments, or you are looking to recruit that next investigator. Meetings International is providing an opportunity to advertise and connect with experts and leaders across the world. Advertisement banners must be provided by the advertising company and must be in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement. Meetings International has so far received 644,430 sessions which confirms the outstanding pool of new users and visitors. Meetings International works on the Open Access publishing model, hence they are the best choice for scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication, and circulation of the published material worldwide within no time while enhancing the visibility of the authors and conferring credibility to scholars and readers. The promotion of the individual author contributions is taken care of and hence the authors enjoy a reputation among the global audience. Meetings International values the contributions of the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving them as well.

Meetings International is announcing the Young Scientist Awards through the 3^rd International Conference on ENT which is scheduled in Paris, France during March 29-30, 2023. This ENT 2023 focuses on the theme of "Advanced therapies for ENT". The ENT meeting and upcoming conferences will recognize participants who have significantly added value to the scientific community of Medical science and provide them with outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences. The conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master's students, Ph.D. students, and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars, and Final Year MSc and M.Phil. Candidates and Persons from Scientific Industry can also participate.
Benefits:
The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.
Acknowledgment as YRF Awardee.
Promotion on the conference website, Young Scientist Awards, and certificates.
Link on the conference website.
Recognition on Meetings Int. Award Page.
Chances to coordinate with partners around the world.
Research work can be published in the relevant journal without any publication fee.
Criteria:
All presented abstracts will automatically be considered for the Award.
All the presentations will be evaluated in the conference venue.
All the awards will be selected by the judges of the award category.
The winners of the Young Scientist Award will receive an award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
Guidelines:
All submissions must be in English.
The topic must fit into the scientific sessions of the conference.
Each individual participant is allowed to submit a maximum of 2 papers.
The abstract must be submitted online as per the given abstract template.
Abstracts must be written in Times New Roman and the font size will be 12.
An abstract must contain a title, name, affiliation, country, speaker's biography, recent photograph, image, and reference.
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with the author's permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of the award.
Award Announcements:
The official announcement of the recipients will occur after the completion of ENT 2023.